[The therapeutic importance of cimetidine (Tagamet) (author's transl)].
An overview of the development, actions and clinical applications of cimetidine, a new histamine H2 receptor antagonist, is given with reference to the literature. The experience of various investigators with this drug in the treatment of peptic ulcer disease are compared with each other and further indications described. The present results suggest a high therapeutic efficacy with trifling side effects. The latter is discussed with reference to two of our own observations. As long as the side effects are not sufficiently known, it is recommended that indications should be restricted to serious recurrent ulcer disease, reflux disease, prophylaxis and treatment of acute life-threatening hemorrhages and for palliative therapy of the Zollinger-Ellison syndrome.
D000328:Adult; D002927:Cimetidine / Q000009:adverse effects / Q000627:therapeutic use*; D003967:Diarrhea / Q000139:chemically induced; D005260:Female; D005687:Galactorrhea / Q000139:chemically induced; D005756:Gastritis / Q000188:drug therapy; D006146:Guanidines / Q000627:therapeutic use*; D006177:Gynecomastia / Q000139:chemically induced; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007408:Intestinal Absorption; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010166:Palliative Care; D010437:Peptic Ulcer / Q000188:drug therapy*; D010438:Peptic Ulcer Hemorrhage / Q000517:prevention & control; D011247:Pregnancy; D011507:Proteinuria / Q000139:chemically induced; D011832:Radiation Injuries / Q000188:drug therapy; D015043:Zollinger-Ellison Syndrome / Q000188:drug therapy
D006146:Guanidines; D002927:Cimetidine
Die therapeutische Bedeutung von Cimetidin (Tagamet).